EMEA-000117-PIP02-10-M07

Key facts

Invented name
Yervoy
Active substance
Ipilimumab
Therapeutic area
Oncology
Decision number
P/0003/2017
PIP number
EMEA-000117-PIP02-10-M07
Pharmaceutical form(s)
Concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of melanoma
Route(s) of administration
Intravenous use
Contact for public enquiries
Bristol-Myers Squibb Pharma EEIG

United Kingdom
Tel. +44 (0)1895 523740
Fax +44 (0)1895 523677
E-mail: medical.information@bms.com

Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-000117-PIP02-10-M07
Compliance opinion date
24/02/2017
Compliance outcome
positive

Decision

How useful was this page?

Add your rating